XDx Registers for IPO

Brisbane, Calif.-based biotech firm XDx Inc. on Wednesday announced that it has filed a registration statement with the U.S. Securities and Exchange Commission for a proposed initial public offering of its common stock.

XDx specializes in molecular diagnostics for the monitoring of transplant rejection and autoimmune diseases.

businessBusiness & Real Estate

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/
Previous story
Bad day for BEA after nixing Oracle bid
Next story
Republicans missing the message

Just Posted

SF speeds up testing for first responders as Sheriff’s Department is hit by coronavirus

Miyamoto rolls out daily temperature checks at jails, hospitals and courthouses

‘Outbreak’ expected at Laguna Honda Hospital after seven test positive for virus

The day after the first patient at Laguna Honda Hospital tested positive… Continue reading

Gov. Newsom orders statewide ban on evictions for renters affected by coronavirus

The measure prevents the evictions of renters over the nonpayment of rent through May 31

San Francisco 911 dispatcher tests positive for coronavirus

Union seeks additional testing for Call Center workers

Breed urges residents to ‘stay home’ as coronavirus cases reach 279

Multiple parking lots closed to discourage prohibited gatherings at beaches, parks

Most Read